2022
DOI: 10.1371/journal.pone.0275026
|View full text |Cite
|
Sign up to set email alerts
|

Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort

Abstract: Objective To compare the likelihood of achieving remission between men and women with rheumatoid arthritis (RA) after starting their first biologic or targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD). Methods This cohort study in the Swiss Clinical Quality Management in Rheumatic Diseases (SCQM) registry included RA patients starting their first b/tsDMARD (1997-31/04/2018). The odds of achieving remission at ≤12-months, defined by disease activity score 28-joints (DAS28) <2.6, were com… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 46 publications
1
1
0
Order By: Relevance
“…Consistent with these findings, low disease activity, including low CRP/BSR levels, and low HAQ levels have also been associated with good future outcomes in patients with RA in previous studies [31, 32]. Similarly, autoantibody status and gender have been described before as predictors of outcomes in RA patients [3234].…”
Section: Discussionsupporting
confidence: 76%
“…Consistent with these findings, low disease activity, including low CRP/BSR levels, and low HAQ levels have also been associated with good future outcomes in patients with RA in previous studies [31, 32]. Similarly, autoantibody status and gender have been described before as predictors of outcomes in RA patients [3234].…”
Section: Discussionsupporting
confidence: 76%
“…Consistent with these findings, low disease activity, including low CRP/BSR levels, and low HAQ levels have also been associated with good future outcomes in patients with RA in previous studies [ 31 , 32 ]. Similarly, autoantibody status and gender have been described before as predictors of outcomes in RA patients [ 32 34 ]. Importantly, this analysis could be expanded to evaluate the influence of additional features not currently in the database, which might be linked to disease activity, such as ethnicity, and their effects on model predictions [ 35 ].…”
Section: Discussionmentioning
confidence: 86%